ACY1 Up (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with ACY1 Up.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with ACY1 Up.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with ACY1 Up.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with ACY1 Up.

Results found

Linked to

 

Label

Description

 

Gene

ENSG00000125657 - TNF superfamily member 9

Gene

ENSG00000131759 - retinoic acid receptor alpha

Gene

ENSG00000116698 - SMG7 nonsense mediated mRNA decay factor

Gene

ENSG00000169575 - V-set pre-B cell surrogate light chain 1

Gene

ENSG00000100614 - protein phosphatase, Mg2+/Mn2+ dependent 1A

Gene

ENSG00000131037 - EPS8 signaling adaptor L1

Gene

ENSG00000111215 - proline rich 4

Gene

ENSG00000173991 - titin-cap

Gene

ENSG00000109061 - myosin heavy chain 1

  • Gene

    ENSG00000125657 - TNF superfamily member 9


  • Gene

    ENSG00000131759 - retinoic acid receptor alpha


  • Gene

    ENSG00000116698 - SMG7 nonsense mediated mRNA decay factor


  • Gene

    ENSG00000169575 - V-set pre-B cell surrogate light chain 1


  • Gene

    ENSG00000100614 - protein phosphatase, Mg2+/Mn2+ dependent 1A


  • Gene

    ENSG00000131037 - EPS8 signaling adaptor L1


  • Gene

    ENSG00000111215 - proline rich 4


  • Gene

    ENSG00000173991 - titin-cap


  • Gene

    ENSG00000109061 - myosin heavy chain 1

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.